BNTC · Benitec Biopharma Inc. · Insider Trading

$9.54 +0.90 (+10.42%) At close · Nov 6

Russell 2000 member Rebalance outlook locked

Market Cap

$332.78M

34.88M

Volume · Nov 6 120.37K Avg daily vol (3M) 186.02K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-29	BUCHI J KEVIN	Director	Gift↓ Filing footnotes — Common Stock (Direct) The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code.	Common Stock	51,813	—	—	52,097
2026-05-26	Friedman David Matthew	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as a Managing Director of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital, the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service. The Options will vest in full on the earlier of immediately prior to the Issuer's next annual meeting of stockholders and May 26, 2027.	Options (right to buy)	35,000	—	—	35,000
2026-01-22	Mates Sharon	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	31,500	—	—	31,500
2025-12-29	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	65,800	$13.44	$884,352	9,700,195
2025-12-29	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	11,587	$13.44	$155,729	1,848,156
2025-12-26	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	2,516	$13.10	$32,960	1,836,569
2025-12-26	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	14,320	$13.10	$187,592	9,634,395
2025-12-23	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	7,400	$12.85	$95,090	1,834,053
2025-12-23	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	42,600	$12.85	$547,410	9,620,075
2025-12-22	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	2,892	$12.08	$34,935	1,826,653
2025-12-22	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	16,650	$12.08	$201,132	9,577,475
2025-12-19	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	13,950	$11.48	$160,146	9,560,825
2025-12-19	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	2,434	$11.48	$27,942	1,823,761
2025-12-18	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	1,515	$11.24	$17,029	1,821,327
2025-12-18	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	8,700	$11.24	$97,788	9,546,875
2025-12-01	Mehta Kishan	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options. The Funds, and Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service. The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	35,000	—	—	35,000
2025-12-01	Francis Peter	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	35,000	—	—	35,000
2025-12-01	BUCHI J KEVIN	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	35,000	—	—	35,000
2025-12-01	Smith Edward F	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	35,000	—	—	35,000
2025-12-01	Mates Sharon	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.	Options (right to buy)	3,500	—	—	3,500
2025-11-18	Mukadam Sophie	Chief Operating Officer	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.	Options (right to buy)	500,000	—	—	500,000
2025-11-18	Boston Megan	Director, Chief Financial Officer	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.	Options (right to buy)	200,000	—	—	200,000
2025-11-18	Banks Jerel A.	Director, Chief Executive Officer	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.	Options (right to buy)	450,000	—	—	450,000
2025-11-07	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	730,370	$13.50	$9,859,995	9,538,175
2025-11-07	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	751,111	$13.50	$10,139,999	1,819,812
2025-11-05	Mates Sharon	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026.	Options (right to buy)	28,517	—	—	28,517
2025-03-31	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	5,057	$13.22	$66,854	8,807,805
2025-03-31	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	670	$13.22	$8,857	1,068,701
2025-03-31	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	9,503	$12.63	$120,023	8,802,748
2025-03-31	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	1,267	$12.63	$16,002	1,068,031
2025-03-26	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	106,200	$13.00	$1,380,600	1,066,764
2025-03-26	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	793,800	$13.00	$10,319,400	8,793,245
2025-03-12	BUCHI J KEVIN	Director	Gift↑ Filing footnotes — Common Stock (Indirect) On March 12, 2025, the reporting person gifted 103,626 shares of Common Stock to a trust for no consideration. The reporting person is trustee of the trust and the reporting person's son is the sole beneficiary.	Common Stock (I)	103,626	—	—	103,626
2025-03-12	BUCHI J KEVIN	Director	Gift↓	Common Stock	103,626	—	—	284
2025-02-27	BUCHI J KEVIN	Director	Convert↓	Common Warrants (right to buy)	51,813	—	—	0
2025-02-27	BUCHI J KEVIN	Director	Convert↑	Common Stock	51,813	$3.86	$199,998	103,910
2024-12-24	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	2,288	$11.25	$25,740	960,554
2024-12-24	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	17,730	$11.25	$199,463	7,999,455
2024-12-23	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	3,142	$10.98	$34,499	958,266
2024-12-23	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	24,360	$10.98	$267,473	7,981,725
2024-12-09	BUCHI J KEVIN	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.	Options (right to buy)	35,000	—	—	35,000
2024-12-09	Smith Edward F	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.	Options (right to buy)	35,000	—	—	35,000
2024-12-09	Francis Peter	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.	Options (right to buy)	35,000	—	—	35,000
2024-12-09	Banks Jerel A.	Director, Chief Executive Officer	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.	Options (right to buy)	2,310,000	—	—	2,310,000
2024-12-09	Boston Megan	Director, Chief Financial Officer	Award↑ Filing footnotes — Options (right to buy) (Direct) The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.	Options (right to buy)	720,000	—	—	720,000
2024-12-09	Mehta Kishan	Director	Award↑ Filing footnotes — Options (right to buy) (Direct) Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options. The Funds, and Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service. The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.	Options (right to buy)	35,000	—	—	35,000
2024-12-03	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	37,190	$9.60	$357,024	7,957,365
2024-12-03	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	4,810	$9.60	$46,176	955,124
2024-11-20	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	24,360	$10.22	$248,959	7,920,175
2024-11-20	SUVRETTA CAPITAL MANAGEMENT, LLC	Director, 10% Owner	Buy↑ Filing footnotes — Common stock, par value $0.0001 per share (Indirect) Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1.	Common stock, par value $0.0001 per share (I)	3,076	$10.22	$31,437	950,314

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 90 transactions

Key facts CIK 1808898 CUSIP 08205P209 13F (30d) 24 filings 24 filers Visit website Investor relations